Literature DB >> 22187458

B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K.

Minjian Ni1, Alexander W MacFarlane, Michelle Toft, Clifford A Lowell, Kerry S Campbell, Jessica A Hamerman.   

Abstract

Toll-like receptors (TLRs) recognize pathogens and their components, thereby initiating immune responses to infectious organisms. TLR ligation leads to the activation of NF-κB and MAPKs through well-defined pathways, but it has remained unclear how TLR signaling activates PI3K, which provides an inhibitory pathway limiting TLR responses. Here, we show that the signaling adapter B-cell adaptor for PI3K (BCAP) links TLR signaling to PI3K activation. BCAP-deficient macrophages and mice are hyperresponsive to TLR agonists and have reduced PI3K activation. The ability of BCAP to inhibit TLR responses requires its capacity to bind PI3K. BCAP is constitutively phosphorylated and associated with the p85 subunit of PI3K in macrophages. This tyrosine-phosphorylated BCAP is transiently enriched in the membrane fraction in response to LPS treatment, suggesting a model whereby TLR signaling causes the phosphorylation of the small amount of BCAP that is associated with membranes in the resting state or the translocation of phosphorylated BCAP from the cytoplasm to the membrane. This accumulation of tyrosine-phosphorylated BCAP at the membrane with its associated PI3K would then allow for the catalysis of Ptd Ins P2 to Ptd Ins P3 and downstream PI3K-dependent signals. Therefore, BCAP is an essential activator of the PI3K pathway downstream of TLR signaling, providing a brake to limit potentially pathogenic excessive TLR responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22187458      PMCID: PMC3252908          DOI: 10.1073/pnas.1111957108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation.

Authors:  T Okada; A Maeda; A Iwamatsu; K Gotoh; T Kurosaki
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

Review 2.  The phosphoinositide 3-kinase pathway.

Authors:  Lewis C Cantley
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

3.  PI3K-mediated negative feedback regulation of IL-12 production in DCs.

Authors:  Taro Fukao; Masanobu Tanabe; Yasuo Terauchi; Takayuki Ota; Satoshi Matsuda; Tomoichiro Asano; Takashi Kadowaki; Tsutomu Takeuchi; Shigeo Koyasu
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

4.  Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells.

Authors:  F Re; J L Strominger
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

5.  Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for Akt activation in response to CD19 engagement.

Authors:  Kazunori Inabe; Tomohiro Kurosaki
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

6.  Syk is required for integrin signaling in neutrophils.

Authors:  Attila Mócsai; Meijuan Zhou; Fanying Meng; Victor L Tybulewicz; Clifford A Lowell
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

7.  Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide.

Authors:  Michael Martin; Robert E Schifferle; Natalia Cuesta; Stefanie N Vogel; Jannet Katz; Suzanne M Michalek
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

8.  Phosphatidylinositol 3-kinase activity negatively regulates stability of cyclooxygenase 2 mRNA.

Authors:  Martha M Monick; Pamela K Robeff; Noah S Butler; Dawn M Flaherty; A Brent Carter; Michael W Peterson; Gary W Hunninghake
Journal:  J Biol Chem       Date:  2002-06-18       Impact factor: 5.157

9.  The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells.

Authors:  Mausumee Guha; Nigel Mackman
Journal:  J Biol Chem       Date:  2002-06-06       Impact factor: 5.157

10.  Essential immunoregulatory role for BCAP in B cell development and function.

Authors:  Tetsuo Yamazaki; Kiyoshi Takeda; Kumiko Gotoh; Hiroshi Takeshima; Shizuo Akira; Tomohiro Kurosaki
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  48 in total

1.  CD19 controls Toll-like receptor 9 responses in human B cells.

Authors:  Henner Morbach; Jean-Nicolas Schickel; Charlotte Cunningham-Rundles; Mary Ellen Conley; Ismail Reisli; Jose Luis Franco; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

2.  Differential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivo.

Authors:  Rajakumar Mandraju; Sean Murray; James Forman; Chandrashekhar Pasare
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

3.  A Structural View of Negative Regulation of the Toll-like Receptor-Mediated Inflammatory Pathway.

Authors:  Emine Guven-Maiorov; Ozlem Keskin; Attila Gursoy; Ruth Nussinov
Journal:  Biophys J       Date:  2015-08-11       Impact factor: 4.033

Review 4.  Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.

Authors:  Jessica A Hamerman; Jessica Pottle; Minjian Ni; Yantao He; Zhong-Yin Zhang; Jane H Buckner
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

5.  Cutting Edge: BCAP Promotes Lupus-like Disease and TLR-Mediated Type I IFN Induction in Plasmacytoid Dendritic Cells.

Authors:  Talyn Chu; Minjian Ni; Chunmo Chen; Shreeram Akilesh; Jessica A Hamerman
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

Review 6.  Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K.

Authors:  Ty Dale Troutman; J Fernando Bazan; Chandrashekhar Pasare
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

7.  BCAP inhibits proliferation and differentiation of myeloid progenitors in the steady state and during demand situations.

Authors:  Jeffrey M Duggan; Matthew B Buechler; Rebecca M Olson; Tobias M Hohl; Jessica A Hamerman
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

Review 8.  The history of Toll-like receptors - redefining innate immunity.

Authors:  Luke A J O'Neill; Douglas Golenbock; Andrew G Bowie
Journal:  Nat Rev Immunol       Date:  2013-05-17       Impact factor: 53.106

9.  Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.

Authors:  Yi Liu; Xiao-Li Jiang; Yu Liu; Ding-Sheng Jiang; Yan Zhang; Rui Zhang; Yingjie Chen; Qinglin Yang; Xiao-Dong Zhang; Guo-Chang Fan; Hongliang Li
Journal:  Cardiovasc Res       Date:  2013-11-26       Impact factor: 10.787

10.  Signaling networks in Leishmania macrophages deciphered through integrated systems biology: a mathematical modeling approach.

Authors:  Milsee Mol; Milind S Patole; Shailza Singh
Journal:  Syst Synth Biol       Date:  2013-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.